Estrogen regulation of nuclear matrix-intermediate filament proteins in human breast cancer cells

Journal of Cellular Biochemistry

Volumn 63, Issue 2, 1996, Pages 174-184

  Coutts, Amanda S ^a   Davie, James R ^a   Dotzlaw, Helmut ^a   Murphy, Leigh C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

breast cancer; cytokeratins; hormone independence; nuclear matrix; T 47D5

Indexed keywords

CYTOKERATIN; ENDOGENOUS COMPOUND; ESTROGEN;

ARTICLE; BREAST CANCER; CELL NUCLEUS MATRIX; CELL STRUCTURE; CELLULAR DISTRIBUTION; CYTOSKELETON; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; INTERMEDIATE FILAMENT; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS REGULATION;

ANTIGENS, NUCLEAR; AUTOANTIGENS; BIOLOGICAL MARKERS; BREAST NEOPLASMS; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; HUMANS; INTERMEDIATE FILAMENT PROTEINS; KERATINS; NUCLEAR PROTEINS; RECEPTORS, ESTROGEN; TUMOR CELLS, CULTURED;

EID: 0029853432     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19961101)63:2<174::AID-JCB5>3.0.CO;2-V     Document Type: Article

References (68)

1. Alexander RB, Greene GL, Barrack ER (1987): Estrogen receptors in the nuclear matrix: Direct demonstration using monoclonal antireceptor antibody. Endocrinology 120:1851-1857.
2. Aronica SM, Katzenellenbogen BS (1993): Stimulation of estrogen receptor mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-1. Mol Endocrinol 7:743-752.
3. Bidwell JP, van Wijnen AJ, Fey EG, Dworetzky S, Penman S, Stein JL, Lian JB, Stein GS (1993): Osteocalcin gene promoter-binding factors are tissue-specific nuclear matrix components. Proc Natl Acad Sci USA 90:3162-3166.
4. Blum JL, Wicha MS (1988): Role of the cytoskeleton in laminin induced mammary gene expression. J Cell Physiol 135:13-22.
5. Boudreau N, Myers C, Bissell MJ (1995): From laminin to lamin: Regulation of tissue-specific gene expression by the ECM. Trends Cell Biol 5:1-4.
6. Broers JLV, Ramaekers CS, Rot MK, Oostendorp T, Huysmans A, van Muijen GNP, Wagenaar SSC, Vooijs GP (1988): Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies. Cancer Res 48:3221-3229.
7. Brunner N, Boulay V, Fojo A, Freter CE, Lippman ME, Clarke R (1993): Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications. Cancer Res 53:283-290.
8. Carter KC, Bowman D, Carrington W, Fogarty K, McNeill JA, Fay FS, Lawrence JB (1993): A three-dimensional view of precursor messenger RNA metabolism within the mammalian nucleus. Science 259:1330-1335.
9. Clarke R, Brunner N, Katzenellenbogen BS, Thompson EW, Norman MJ, Koppi C, Paik S, Lippman ME, Dickson RB (1989): Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo. Proc Natl Acad Sci USA 86:3649-3653.
10. Clarke R, Dickson RB, Brunner N (1990): The process of malignant progression in human breast cancer. Ann Oncol 1:401-407.
11. Clarke R, Skaar T, Baumann K, Leonessa F, James M, Lippman J, Thompson EW, Freter C, Brunner N (1994): Hormonal carcinogenesis in breast cancer: Cellular and molecular studies of malignant progression. Breast Cancer Res Treat 31:237-248.
12. Cook PR (1991): The nucleoskeleton and the topology of replication. Cell 66:627-635.
13. Cooper MP, Braakhuis BJM, deVries N, van Dongen GAMS, Nauta JJP, Snow GB (1993): A panel of biomarkers of carcinogenesis of the upper aerodigestive tract as potential intermediate endpoints in chemoprevention trials. Cancer 71:825-830.
14. Delcuve GP, Davie JR (1991): Western blotting and immunochemical detection of histones electrophoretically resolved on acid-urea-triton- and sodium dodecyl sulfate-polyacrylamide gels. Anal Biochem 200:339-341.
15. Dickson RB, Lippman ME (1991): Growth regulation of normal and malignant breast epithelium. In Bland KI, Copeland EM (eds): "The breast: Comprehensive management of benign and malignant diseases." Philadelphia: WB Saunders, pp 363-394.
16. Djabali K, Portier M-M, Gros F, Blobel G, Georgatos SD (1991): Network antibodies identify nuclear lamin B as a physiological attachment site for peripherin intermediate filaments. Cell 64:109-121.
17. Doucet JP, Trifaro JM (1988): A discontinuous and highly porous sodium dodecyl sulfate-polyacylamide slab gel system of high resolution. Anal Biochem 168:265-271.
18. Dworetsky SI, Fey EG, Penman S, Lian JB, Stein GS (1990): Progressive changes in the protein composition of the nuclear matrix during rat osteoblast differentiation. Proc Natl Acad Sci USA 87:4605-4609.
19. Ferrero M, Spyratos F, Le Doussal V, Desplaces A, Rouesse J (1990): Flow cytometric analysis of DNA content and keratins using CK7, CK8, CK18, CK19 and KL1 monoclonal antibodies in benign and malignant human breast tumors. Cytometry 11:716-724.
20. Fey EG, Penman S (1981): Tumor promoters induce a specific morphological signature in the nuclear matrix in intermediate filament scaffold of Madin-Darby canine kidney (MDCK) cell colonies. Proc Natl Acad Sci USA 81:859-866.
21. Fey EG, Penman S (1989): Nuclear matrix proteins reflect cell type of origin in cultured human cells. Proc Natl Acad Sci USA 85:121-125.
22. Fey EG, Wan KM, Penman S (1984): Epithelial cytoskeletal framework and nuclear matrix-intermediate filament scaffold: Three-dimensional organization and protein composition. J Cell Biol 98:1973-1984.
23. Georgatos SD, Blobel G (1987): Lamin B constitutes an intermediate filament attachment site at the nuclear envelope. J Cell Biol 105:117-125.
24. Gerdes MG, Carter KC, Moen PT Jr, Lawrence JB (1994): Dynamic changes in the higher-level chromatin organization of specific sequences revealed by in situ hybridization to nuclear halos. J Cell Biol 126:289-304.
25. Getzenberg RH, Coffey DS (1990): Tissue specificity of the hormonal response in sex accessory tissues is associated with nuclear matrix protein patterns. Mol Endocrinol 4:1336-1342.
26. Getzenberg RH, Coffey DS (1991): Interaction of tissue specific genes with tissue specific nuclear matrix proteins in rat sex accessory tissues. J Cell Biol 115:121A.
27. Getzenberg RH, Pienta KJ, Ward WS, Coffey DS (1991): Nuclear structure and the three-dimensional organization of DNA. J Cell Biochem 47:289-299.
28. 1-induced carcinogenesis. Carcinogenesis 11:1175-1182.
29. Heukeshoven J, Dernick R (1985): Simplified method for silver staining of proteins in polyacrylamide gels and mechanism of silver staining. Electrophoresis 6:103-112.
30. Hozak P, Sasseville AM-J, Raymond Y, Cook PR (1995): Lamin proteins form an internal nucleoskeleton as well as a peripheral lamina in human cells. J Cell Sci 108:635-644.
31. Hsieh J-T, Zhau HE, Wang X-H, Liew C-C, Chung LWK (1992): Regulation of basal and luminal cell-specific cytokeratin expression in rat accessory sex organs. J Biol Chem 267:2303-2310.
32. Huang S, Spector DL (1991): Nascent pre-mRNA transcripts are associated with nuclear regions enriched in splicing factors. Genes Dev 5:2288-2302.
33. Ignar-Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS, McLachlan JA (1993): Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol 7:992-998.
34. Jordan VC (1988): The development of tamoxifen for breast cancer therapy: Tribute to the late Arthur L. Walpole. Breast Cancer Res Treat 11:197-209.
35. Kannan S, Balaram P, Chandran GJ, Pillai MR, Mathew B, Nalinakumari KR, Nair MK (1994a): Differential expression of cytokeratin proteins during tumour progression in oral muscosa. Epithelial Cell Biol 3:61-69.
36. Kannan S, Balaram P, Chandran GJ, Pillai MR, Mathew B, Nalinakumari KR, Nair MK (1994b): Alterations in expression of terminal differentiation markers of keratinocytes during oral carcinogenesis. Pathobiology 62:127-133.
37. Katzenellenbogen BS, Kendra KL, Norman MJ, Berthois Y (1987): Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res 47:4355-4360.
38. Khanuja PS, Lehr JE, Soule HD, Gehani SK, Noto AC, Choudhury S, Chen R, Pienta KJ (1993): Nuclear matrix proteins in normal and breast cancer cells. Cancer Res 53:3394-3398.
39. Kirsch TM, Miller-Diener A, Litwack G (1986): The nuclear matrix is the site of glucocorticoid receptor complex action in the nucleus. Biochem Biophys Res Commun 137:640-648.
40. Kronenberg MS, Clark JH (1985): Changes in keratin expression during the estrogen-mediated differentiation of rat vaginal epithellium. Endocrinology 117:1480-1489.
41. Laemmli UK (1970): Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
42. Leonessa F, Boulay B, Wright A, Thompson EW, Brunner N, Clarke R (1991): The biology of breast tumor progression: Acquisition of hormone-independence and resistance to cytotoxic drugs. Acta Oncol 31:115-123.
43. Martell RE, Strahler JR, Simpson RU (1992): Identification of lamin B and histones as 1,25-dihydroxyvitamin D3-regulated nuclear phosphoproteins in HL-60 cells. J Biol Chem 267:7511-7519.
44. Metzger DA, Korach KS (1990): Cell-free interaction of the estrogen receptor with mouse uterine nuclear matrix: Evidence of saturability, specificity, and resistance to KC1 extraction. Endocrinology 126:2190-2195.
45. Moll R, Franke WW, Schiller DL (1982): The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24.
46. Murphy LC, Dotzlaw H (1989): Endogenous growth factor expression in T-47D, human breast cancer cells, associated with reduced sensitivity to antiproliferative effects of progestins and antiestrogens. Cancer Res 49:599-604.
47. Murphy LC, Dotzlaw H, Wong MSJ, Miller T, Mrockowski B, Gong Y, Murphy LJ (1990): Epidermal growth factor: Receptor and ligand expression in human breast cancer. Semin Cancer Biol 1:305-315.
48. O'Farrell PH (1975): High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250:4007-4021.
49. Partin AW, Getzenberg RH, CarMichael MJ, Vindivich D, Yoo J, Epstein JI, Coffey DS (1993): Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res 53:744-746.
50. Pienta KJ, Coffey DS (1992): Nuclear-cytoskeletal interactions: Evidence for physical connections between the nucleus and cell periphery and their alteration by transformation. J Cell Biochem 49:357-365.
51. Pienta KJ, Hoover CN (1994): Coupling of cell structure to cell metabolism and function. J Cell Biochem 55:16-21.
52. Prasad S, Kuettel M, Rhim J, Thraves J, Dritschilo A (1993): Differential expression of nuclear matrix proteins in v-Ki-ras transformed human prostate epithelial cells. Proc American Association of Cancer Research 35:184.
53. Read LD, Greene GL, Katzenellenbogen BS (1989): Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Mol Endocrinol 3:295-304.
54. Sapino A, Pietribiasi F, Bussolati G, Marchisio PC (1986): Estrogen- and tamoxifen-induced rearrangement of cytoskeletal and adhesion structures in breast cancer MCF-7 cells. Cancer Res 46:2526-2531.
55. Seely KA, Aggeler J (1991): Modulation of milk protein synthesis through alteration of the cytoskeleton in mouse mammary epithelial cells cultured on a reconstituted basement membrane. J Cell Physiol 146:117-130.
56. Shiu RPC (1979): Prolactin receptors in human breast cancer cells in long term culture. Cancer Res 39:4381-4386.
57. Sommers CL, Walker-Jones D, Heckford SE, Worland P, Valverius E, Clark R, McCormick F, Stampfer M, Abularach S, Gelmann EP (1989): Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells. Cancer Res 49:4258-4263.
58. Sommers CL, Heckford SE, Skerker JM, Worland P, Torri JA, Thompson EW, Byers SW, Gelmann EP (1992): Loss of epithelial markers and acquisition of vimentin expression in Adriamycin- and vinblastine-resistant human breast cancer cell lines. Cancer Res 52:5190-5197.
59. Stein GS, van Wijnen AJ, Stein JL, Lian GB, Bidwell JP, Montecino M (1994): Nuclear architecture supports integration of physiological regulatory signals for transcription of cell growth and tissue-specific genes during osteoblast differentiation. J Cell Biochem 55:4-15.
60. Streuli CH, Schmidhauser C, Bailey N, Yurchenco P, Skubitz APN, Roskelley C, Bissell MJ (1995): Laminin mediates tissue-specific gene expression in mammary epithelia. J Cell Biol 129:591-603.
61. Sun J-M, Chen HY, Davie JR (1994): Nuclear factor 1 is a component of the nuclear matrix. J Cell Biochem 55:252-263.
62. Traub P, Nelson WJ, Kuhn S, Vorgia CE (1983): The interaction in vitro of the intermediate filament protein vimentin with naturally occurring RNAs and DNAs. J Biol Chem 258:1456-1466.
63. van Agthoven T, van Agthoven TLA, Portengen H, Foekens JA, Dorssers LCJ (1992): Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells. Cancer Res 52:5082-5088.
64. van Agthoven T, van Agthoven TLA, Foekens JA, Dorssers LCJ (1993): Regulation of gene expression involved in the progression of human breast cancer to hormone independence. Ann NY Acad Sci 684:250-252.
65. van Agthoven T, van Agthoven TLA, Dekker A, Foekens JA, Dorssers LCJ (1994): Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations. Mol Endocrinol 8:1474-1483.
66. Watts CKW, Handel ML, King RJB, Sutherland RL (1992): Oestrogen receptor gene structure and function in breast cancer. J Steroid Biochem Mol Biol 41:529-536.
67. Xing Y, Johnson CV, Dobner PR, Lawrence JB (1993): Higher level organization of individual gene transcription and RNA splicing. Science 259:1326-1330.
68. Zambetti G, Ramsey-Ewing A, Bortell R, Stein G, Stein J (1991): Disruption of the cytoskeleton with cytochalasin D induces c-fos gene expression. Exp Cell Res 192:93-101.